SJM Confirm® Implantable Cardiac Monitor

Syncope is a common and disabling condition that is associated with an increased risk of morbidity and mortality and remains difficult to diagnose.¹ Medical literature reports that a diagnosis is possible in up to 90% of patients with syncope using an implantable monitor.²

The SJM Confirm ICM is an integrated system consisting of the implantable device used for automatic-triggered event storage, the handheld, external device called the Patient Activator used for patient-triggered event storage, and the Merlin^® Patient Care System, which provides communication, data retrieval and programming capabilities.

Streamline Implantation with Minimally Invasive Device

• Small size – at 6.5 cc – the smallest ICM on the market
• Excellent longevity – three years
• Subcutaneous electrodes for simplified procedure

Improve Signal Detection

• Proven SenseAbility^® technology designed for accurate sensing over a wide range of signals
• Detection inhibitors for noise response and activity response 
  

Customize and Prioritize Data Storage Options

• Compatibility with Merlin Patient Care System (PCS)
• Patient-triggered activation option for EGM storage
• Additional programming options – tachycardia, bradycardia, asystole
• 48 minutes of stored electrograms (147 episodes)
• Data storage options for flexibility

Receive Vital Information through Extensive Data Reports

• Comprehensive diagnostic data to assist in patient management
• Transtelephonic monitoring for timely and accurate data transmission

¹ Kapoor WN. Syncope. N Engl J Med 2000: 343: 1856-61.

² Krahn AD, Klein GJ, Yee R et al. Use of an extended monitoring strategy in patients with problematic syncope. Circulation 1999; 99: 406-10.

SJM Confirm ICM DM2100 Spec Sheet [PDF]